Seebri and Acute kidney failure - a phase IV clinical study of FDA data

Summary:

Acute kidney failure is reported as a side effect among people who take Seebri (glycopyrrolate), especially for people who are male, 60+ old, also take Lantus, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Acute kidney failure when taking Seebri. It is created by eHealthMe based on reports of 2,613 people who have side effects when taking Seebri from the FDA, and is updated regularly.

What is Seebri?

Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.

What is Acute kidney failure?

Acute kidney failure is found to be associated with 2,835 drugs and 4,492 conditions by eHealthMe. Check the latest studies of Acute kidney failure.

On Jul, 19, 2026

2,613 people reported to have side effects when taking Seebri.
Among them, 42 people (1.61%) have Acute kidney failure.

Could Seebri cause Acute kidney failure?

Among these 42 people:

What is the gender of people who have Acute kidney failure when taking Seebri? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Acute kidney failure when taking Seebri? *

What are other drugs people take besides Seebri? *

What are other side effects people have besides Acute kidney failure? *

Nausea (feeling of having an urge to vomit): 21 people, 50.00%
Visual Impairment: 21 people, 50.00%
Oedema Peripheral (superficial swelling): 20 people, 47.62%
Hepatocellular Injury (liver injury): 20 people, 47.62%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 20 people, 47.62%
Hypotension (abnormally low blood pressure): 20 people, 47.62%
Hypoglycemia (low blood sugar): 20 people, 47.62%
Hepatic Failure (liver failure): 20 people, 47.62%
Asthma: 5 people, 11.90%
Fatigue (feeling of tiredness): 5 people, 11.90%

What are the existing conditions these people have? *

Type 2 Diabetes: 23 people, 54.76%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 20 people, 47.62%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 20 people, 47.62%
Asthma: 7 people, 16.67%
High Blood Pressure: 4 people, 9.52%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 7.14%
Back Pain: 2 people, 4.76%
Septic Shock (shock due to blood infection): 2 people, 4.76%
Sinusitis (inflammation of sinus): 2 people, 4.76%
Dyslipidaemia (abnormal amount of lipids): 2 people, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Seebri and have Acute kidney failure?

- Check whether Acute kidney failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Seebri:

Seebri (2,618 reports)

Browse all side effects of Seebri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute kidney failure:

Acute kidney failure (2,835 drugs)

Browse all the conditions that are associated with Acute kidney failure:

Acute kidney failure (4,492 conditions)

Related publications that referenced our studies

D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Seebri) and Seebri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.